Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mantel

Showing results (571-580 of 1,338) with videos related to

Pageof 134
Sort By:
Pharmacoepidemiology and Drug Safety|May 26, 2018
Characteristics of drugs safety signals that predict safety related product information updateWidya N Insani, Alexandra C Pacurariu, Aukje K Mantel-Teeuwisse, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 1, 2009
Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP)Lazaros Konstantinidis, Evangelia Mameletzi, Irmela Mantel, et al.
Pharmacoepidemiology and Drug Safety|January 19, 2019
The double opioid crisis: A call for balanceMarjolein J M Vranken, Marie-Hélène D B Schutjens, Aukje K Mantel-Teeuwisse
Retina (Philadelphia, Pa.)|January 26, 2018
MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan RegimenIrmela Mantel, Ali Dirani, Marta Zola, et al.
Scientific Reports|November 9, 2021
Fully-automated atrophy segmentation in dry age-related macular degeneration in optical coherence tomographyYasmine Derradji, Agata Mosinska, Stefanos Apostolopoulos, et al.
Frontiers in Immunology|October 28, 2021
Oxidative and Non-Oxidative Antimicrobial Activities of the GranzymesMarilyne Lavergne, Maria Andrea Hernández-Castañeda, Pierre-Yves Mantel, et al.
Biochemical and Biophysical Research Communications|January 15, 1990
Cloning, sequencing and expression of human TSH receptorM Misrahi, H Loosfelt, M Atger, et al.
Journal of Pharmaceutical Policy and Practice|July 23, 2020
Systematic reviews of ten pharmaceutical pricing policies - a research protocolDavid Tordrup, Hendrika A van den Ham, Julie Glanville, et al.
British Journal of Clinical Pharmacology|October 10, 2012
Future of the European Union regulatory network in the context of the uptake of new medicinesJoëlle M Hoebert, Alar Irs, Aukje K Mantel-Teeuwisse, et al.
Drug Discovery Today|June 3, 2024
Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunityMarcelien H E Callenbach, Wim G Goettsch, Aukje K Mantel-Teeuwisse, et al.
Pageof 134

Showing results (571-580 of 1,338) with videos related to

Sort By:
Pageof 134
Pharmacoepidemiology and Drug Safety|May 26, 2018
Characteristics of drugs safety signals that predict safety related product information updateWidya N Insani, Alexandra C Pacurariu, Aukje K Mantel-Teeuwisse, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 1, 2009
Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP)Lazaros Konstantinidis, Evangelia Mameletzi, Irmela Mantel, et al.
Pharmacoepidemiology and Drug Safety|January 19, 2019
The double opioid crisis: A call for balanceMarjolein J M Vranken, Marie-Hélène D B Schutjens, Aukje K Mantel-Teeuwisse
Retina (Philadelphia, Pa.)|January 26, 2018
MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan RegimenIrmela Mantel, Ali Dirani, Marta Zola, et al.
Scientific Reports|November 9, 2021
Fully-automated atrophy segmentation in dry age-related macular degeneration in optical coherence tomographyYasmine Derradji, Agata Mosinska, Stefanos Apostolopoulos, et al.
Frontiers in Immunology|October 28, 2021
Oxidative and Non-Oxidative Antimicrobial Activities of the GranzymesMarilyne Lavergne, Maria Andrea Hernández-Castañeda, Pierre-Yves Mantel, et al.
Biochemical and Biophysical Research Communications|January 15, 1990
Cloning, sequencing and expression of human TSH receptorM Misrahi, H Loosfelt, M Atger, et al.
Journal of Pharmaceutical Policy and Practice|July 23, 2020
Systematic reviews of ten pharmaceutical pricing policies - a research protocolDavid Tordrup, Hendrika A van den Ham, Julie Glanville, et al.
British Journal of Clinical Pharmacology|October 10, 2012
Future of the European Union regulatory network in the context of the uptake of new medicinesJoëlle M Hoebert, Alar Irs, Aukje K Mantel-Teeuwisse, et al.
Drug Discovery Today|June 3, 2024
Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunityMarcelien H E Callenbach, Wim G Goettsch, Aukje K Mantel-Teeuwisse, et al.
Pageof 134